SCHEMBL22928005

SCHEMBL22928005

CC(C)(C)c1cccc(C(O)(F)F)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.53
HDAC8 Q9BY41 3/20 0.48
HDAC4 P56524 1/20 0.48
HDAC2 Q92769 1/20 0.48
KIF11 P52732 2/20 0.42
PGK1 P00558 1/20 0.42
PGK2 P07205 1/20 0.42
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
RXRA P19793 2/20 0.42
RXRB P28702 2/20 0.42
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
GABRA1 P14867 1/20 0.41
GABRB2 P47870 1/20 0.41
HDAC6 Q9UBN7 2/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9095009 0.86 ACHE (0.53) ACHEHDAC8HDAC4HDAC2KIF11
SCHEMBL25093345 0.83 ACHE (0.50) ACHEHDAC8HDAC4HDAC2KIF11
SCHEMBL17914398 0.83 ACHE (0.50) ACHEHDAC8HDAC4HDAC2KIF11
SCHEMBL19734501 0.83 ACHE (0.50) ACHEHDAC8HDAC4HDAC2ALOX15
SCHEMBL129151 0.83 HDAC8 (0.56) ACHEHDAC8HDAC4HDAC2KIF11
SCHEMBL3966160 0.81 HDAC8 (0.52) ACHEHDAC8HDAC4HDAC2KIF11
SCHEMBL12163579 0.81 ACHE (0.52) ACHEHDAC8HDAC4HDAC2KIF11
SCHEMBL25451230 0.81 ACHE (0.52) ACHEHDAC8HDAC4HDAC2KIF11
SCHEMBL178282 0.81 TSHR (0.54) ACHEHDAC8HDAC4HDAC2KIF11
Water SCHEMBL29289408 0.80 HDAC8 (0.54) ACHEHDAC8HDAC4HDAC2KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210024498-A1 TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF MEDICONNS SHANGHAI BIOPHARMACEUTICAL CO LTD (CN) 2021-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024498-A1 TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF PRLHR, DRD2, AVPR2 ACHE 597/4885HDAC8 4098/4885HDAC4 4022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.